Titchenell. Antibody Blockade of Activin Type II Receptors Preserves Skeletal Muscle Mass and Enhances Fat Loss During GLP-1 Receptor Agonism. Molecular metabolism (Accepted, January, 2024). Impact ...

Biolojic's platform turns human antibodies into programmable switches with specific functions: agonism, antagonism and conditional binding, enhancing their functionality and the precision of their ...